Usefulness of biopsy by office hysteroscopy for endometrial cancer: A case report

por Sone, Kenbun, Eguchi, Satoko, Asada, Kayo, Inoue, Futaba, Miyamoto, Yuichiro, Tanikawa, Michihiro, Tsuruga, Tetsushi, Mori-Uchino, Mayuyo, Matsumoto, Yoko, Hiraike-Wada, Osamu, Oda, Katsutoshi, Osuga, Yutaka, Fujii, Tomoyuki
Publicado 2020

Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade...

por Matsushita, Hirokazu, Hasegawa, Kosei, Oda, Katsutoshi, Yamamoto, Shogo, Asada, Kayo, Karasaki, Takahiro, Yabuno, Akira, Nishijima, Akira, Nejo, Takahide, Kobayashi, Yukari, Sato, Sho, Ikeda, Yuji, Miyai, Manami, Takahashi, Yusuke, Yamaguchi, Rui, Fujiwara, Keiichi, Aburatani, Hiroyuki, Kakimi, Kazuhiro
Publicado 2020

The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation

por Kojima, Machiko, Sone, Kenbun, Oda, Katsutoshi, Hamamoto, Ryuji, Kaneko, Syuzo, Oki, Shinya, Kukita, Asako, Machino, Hidenori, Honjoh, Harunori, Kawata, Yoshiko, Kashiyama, Tomoko, Asada, Kayo, Tanikawa, Michihiro, Mori-Uchino, Mayuyo, Tsuruga, Tetsushi, Nagasaka, Kazunori, Matsumoto, Yoko, Wada-Hiraike, Osamu, Osuga, Yutaka, Fujii, Tomoyuki
Publicado 2019

Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas

por Uehara, Yuriko, Oda, Katsutoshi, Ikeda, Yuji, Koso, Takahiro, Tsuji, Shingo, Yamamoto, Shogo, Asada, Kayo, Sone, Kenbun, Kurikawa, Reiko, Makii, Chinami, Hagiwara, Otoe, Tanikawa, Michihiro, Maeda, Daichi, Hasegawa, Kosei, Nakagawa, Shunsuke, Wada-Hiraike, Osamu, Kawana, Kei, Fukayama, Masashi, Fujiwara, Keiichi, Yano, Tetsu, Osuga, Yutaka, Fujii, Tomoyuki, Aburatani, Hiroyuki
Publicado 2015

Correction: Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carci...

por Uehara, Yuriko, Oda, Katsutoshi, Ikeda, Yuji, Koso, Takahiro, Tsuji, Shingo, Yamamoto, Shogo, Asada, Kayo, Sone, Kenbun, Kurikawa, Reiko, Makii, Chinami, Hagiwara, Otoe, Tanikawa, Michihiro, Maeda, Daichi, Hasegawa, Kosei, Nakagawa, Shunsuke, Wada-Hiraike, Osamu, Kawana, Kei, Fukayama, Masashi, Fujiwara, Keiichi, Yano, Tetsu, Osuga, Yutaka, Fujii, Tomoyuki, Aburatani, Hiroyuki
Publicado 2015

MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53

por Makii, Chinami, Oda, Katsutoshi, Ikeda, Yuji, Sone, Kenbun, Hasegawa, Kosei, Uehara, Yuriko, Nishijima, Akira, Asada, Kayo, Koso, Takahiro, Fukuda, Tomohiko, Inaba, Kanako, Oki, Shinya, Machino, Hidenori, Kojima, Machiko, Kashiyama, Tomoko, Mori-Uchino, Mayuyo, Arimoto, Takahide, Wada-Hiraike, Osamu, Kawana, Kei, Yano, Tetsu, Fujiwara, Keiichi, Aburatani, Hiroyuki, Osuga, Yutaka, Fujii, Tomoyuki
Publicado 2016